Russell Investments Group
HAE icon

Russell Investments Group’s Haemonetics HAE Stock Holding History

Russell Investments Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Buy
35,713
+6,636
+23% +$426K ﹤0.01% 1916
2026
Q1 		$1.64M Sell
29,077
-32,544
-53% -$2.12M ﹤0.01% 1975
2025
Q4 		$4.94M Buy
61,621
+5,604
+10% +$377K 0.01% 1335
2025
Q3 		$2.73M Buy
56,017
+22,537
+67% +$1.4M ﹤0.01% 1693
2025
Q2 		$2.5M Sell
33,480
-1,618
-5% -$107K ﹤0.01% 1616
2025
Q1 		$2.23M Buy
35,098
+1,495
+4% +$102K ﹤0.01% 1632
2024
Q4 		$2.62M Sell
33,603
-2,997
-8% -$241K ﹤0.01% 1528
2024
Q3 		$2.94M Buy
36,600
+995
+3% +$80.4K ﹤0.01% 1484
2024
Q2 		$2.95M Sell
35,605
-128
-0.4% -$11.3K ﹤0.01% 1436
2024
Q1 		$3.05M Buy
35,733
+828
+2% +$65K ﹤0.01% 1419
2023
Q4 		$2.98M Buy
34,905
+2,006
+6% +$173K 0.01% 1400
2023
Q3 		$2.95M Sell
32,899
-6,495
-16% -$580K 0.01% 1343
2023
Q2 		$3.35M Sell
39,394
-1,774
-4% -$150K 0.01% 1263
2023
Q1 		$3.41M Buy
41,168
+9,083
+28% +$735K 0.01% 1284
2022
Q4 		$2.52M Buy
32,085
+1,506
+5% +$121K 0.01% 1445
2022
Q3 		$2.26M Sell
30,579
-55,586
-65% -$3.99M 0.01% 1483
2022
Q2 		$5.61M Buy
86,165
+7,819
+10% +$463K 0.01% 1039
2022
Q1 		$4.95M Sell
78,346
-3,146
-4% -$171K 0.01% 1157
2021
Q4 		$4.32M Sell
81,492
-233,234
-74% -$14.2M 0.01% 1342
2021
Q3 		$22.2M Buy
314,726
+66,684
+27% +$4.21M 0.04% 552
2021
Q2 		$16.5M Buy
248,042
+213,440
+617% +$15.1M 0.03% 682
2021
Q1 		$3.84M Buy
34,602
+2,797
+9% +$346K 0.01% 1496
2020
Q4 		$3.77M Sell
31,805
-2,624
-8% -$282K 0.01% 1398
2020
Q3 		$3M Sell
34,429
-21,929
-39% -$1.92M 0.01% 1428
2020
Q2 		$5.04M Sell
56,358
-40,929
-42% -$4.13M 0.01% 1091
2020
Q1 		$9.78M Sell
97,287
-96,588
-50% -$10.5M 0.03% 660
2019
Q4 		$22.2M Sell
193,875
-33,457
-15% -$4.05M 0.04% 504
2019
Q3 		$28.4M Sell
227,332
-1,548
-0.7% -$196K 0.06% 394
2019
Q2 		$27.4M Sell
228,880
-42,726
-16% -$4.2M 0.05% 432
2019
Q1 		$23.5M Buy
271,606
+15,741
+6% +$1.43M 0.04% 511
2018
Q4 		$25M Sell
255,865
-84,875
-25% -$8.92M 0.06% 398
2018
Q3 		$38.8M Buy
340,740
+140,505
+70% +$14.5M 0.07% 299
2018
Q2 		$17.9M Buy
200,235
+66,748
+50% +$5.64M 0.04% 588
2018
Q1 		$9.77M Buy
133,487
+59,769
+81% +$4.1M 0.02% 993
2017
Q4 		$4.3M Buy
73,718
+31,737
+76% +$1.67M 0.01% 1434
2017
Q3 		$1.88M Buy
41,981
+18,478
+79% +$768K ﹤0.01% 1817
2017
Q2 		$928K Buy
23,503
+2,553
+12% +$105K ﹤0.01% 2149
2017
Q1 		$850K Sell
20,950
-2,619
-11% -$102K ﹤0.01% 2185
2016
Q4 		$942K Buy
+23,569
New +$889K ﹤0.01% 2200

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Russell Investments Group's HAE Position: Q2 2026 in Review

Russell Investments Group increased its Haemonetics (HAE) stake by 23% in Q2 2026, buying an estimated $426K and bringing the position to 35,713 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1916.

Russell Investments Group first reported a position in HAE in Q4 2016 and has held it in 39 quarters since. The position peaked at $38.8M in Q3 2018. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Russell Investments Group held 35,713 shares of Haemonetics worth $2.68M as of Q2 2026.
  • Russell Investments Group bought 6,636 Haemonetics shares in Q2 2026, an estimated $426K.
  • Haemonetics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1916 holding.
  • Russell Investments Group first reported a position in Haemonetics in Q4 2016 and has held it in 39 quarters since.
  • Russell Investments Group's Haemonetics position peaked at $38.8M in Q3 2018.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.